63
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Helicobacter pylori infection and short-term intake of low-dose aspirin have different effects on alpha-1 antitrypsin/alpha-1 peptidase inhibitor (α1-PI) levels in antral mucosa and peripheral blood

, PhD, , , , , & show all
Pages 1194-1201 | Received 10 Nov 2007, Published online: 08 Jul 2009

References

  • Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161–81
  • Matysiak-Budnik T, Laszewicz W, Lamarque D, Chaussade S. Helicobacter pylori and non-malignant diseases. Helicobacter 2006;11 Suppl 1:27–31.
  • Lanas A, Scheiman J. Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment. Curr Med Res Opin 2007; 23: 163–73
  • Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007; 56: 772–81
  • Venerito M, Treiber G, Wex T, Kuester D, Roessner A, Di Mario F, et al. Effects of low-dose aspirin on gastric erosions, cyclooxygenase expression and mucosal prostaglandin-E2 do not depend on Helicobacter pylori infection. Aliment Pharmacol Ther 2006; 23: 1225–33
  • Wex T, Ye S, Treiber G, Vieth M, Roessner A, Malfertheiner P. Helicobacter pylori infection, but not low-dose aspirin, results in a local reduction of the secretory leukocyte protease inhibitor in gastroduodenal mucosa. Helicobacter 2006; 11: 31–8
  • Fitch PM, Roghanian A, Howie SE, Sallenave JM. Human neutrophil elastase inhibitors in innate and adaptive immunity. Biochem Soc Trans 2006; 34: 279–82
  • Mulgrew AT, Taggart CC, McElvaney NG. Alpha-1-antitrypsin deficiency: current concepts. Lung 2007; 185: 191–201
  • Dobo J, Gettins PG. Alpha1-proteinase inhibitor forms initial non-covalent and final covalent complexes with elastase analogously to other serpin-proteinase pairs, suggesting a common mechanism of inhibition. J Biol Chem 2004; 279: 9264–9
  • Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002; 347: 1175–86
  • Shahid A, Siddiqui AA, Sultana T, Qureshi H, Waqar MA, Zuberi SJ. Determination of alpha-1 antitrypsin genetic deficiency in duodenal ulcer by polymerase chain reaction. J Pak Med Assoc 2002; 52: 545–58
  • Elzouki AN, Toth E, Floren CH, Lindgren S, Fork FT, Sjolund K, et al. Alpha1-antitrypsin deficiency may be a risk factor for duodenal ulcer in patients with Helicobacter pylori infection. Scand J Gastroenterol 2000; 35: 32–5
  • Allgayer H, Babic R, Grutzner KU, Beyer BC, Tarabichi A, Schildberg FW, et al. Tumor-associated proteases and inhibitors in gastric cancer: analysis of prognostic impact and individual risk protease patterns. Clin Exp Metastasis 1998; 16: 62–73
  • Lee K, Kye M, Jang JS, Lee OJ, Kim T, Lim D. Proteomic analysis revealed a strong association of a high level of alpha1-antitrypsin in gastric juice with gastric cancer. Proteomics 2004; 4: 3343–52
  • Hsu PI, Chen CH, Hsieh CS, Chang WC, Lai KH, Lo GH, et al. Alpha1-antitrypsin precursor in gastric juice is a novel biomarker for gastric cancer and ulcer. Clin Cancer Res 2007; 13: 876–83
  • Hafeez W, Ciliberto G, Perlmutter DH. Constitutive and modulated expression of the human alpha 1 antitrypsin gene. Different transcriptional initiation sites used in three different cell types. J Clin Invest 1992; 89: 1214–22
  • Kalsheker N, Morley S, Morgan K. Gene regulation of the serine proteinase inhibitors alpha1-antitrypsin and alpha1-antichymotrypsin. Biochem Soc Trans. 2002; 30: 93–8
  • Sallenave JM, Tremblay GM, Gauldie J, Richards CD. Oncostatin M, but not interleukin-6 or leukemia inhibitory factor, stimulates expression of alpha1-proteinase inhibitor in A549 human alveolar epithelial cells. J Interferon Cytokine Res 1997; 17: 337–46
  • Faust D, Raschke K, Hormann S, Milovic V, Stein J. Regulation of alpha1-proteinase inhibitor release by proinflammatory cytokines in human intestinal epithelial cells. Clin Exp Immunol 2002; 128: 279–84
  • Hatakeyama M, Brzozowski T. Pathogenesis of Helicobacter pylori infection. Helicobacter 2006;11 Suppl 1:14–20.
  • Kandulski A, Wex T, Kuester D, Peitz U, Gebert I, Roessner A, , et al. Helicobacter pylori-induced infiltration of regulatory T cells (CD4+, CD25high, FOXP3 + ) into gastric mucosa is associated with bacterial colonization and expression of the regulatory cytokine TGF-β1. Helicobacter 2008. In press.
  • Dzierzanowska-Fangrat K, Michalkiewicz J, Cielecka-Kuszyk J, Nowak M, Celinska-Cedro D, Rozynek E, et al. Enhanced gastric IL-18 mRNA expression in Helicobacter pylori-infected children is associated with macrophage infiltration, IL-8, and IL-1beta mRNA expression. Eur J Gastroenterol Hepatol 2008; 20: 314–9
  • Mulholland G, Ardill JE, Fillmore D, Chittajallu RS, Fullarton GM, McColl KE. Helicobacter pylori related hypergastrinaemia is the result of a selective increase in gastrin 17. Gut 1993; 34: 757–61
  • Tokushima H, Tamura H, Murakawa M, Matsumura O, Itakura Y, Itoyama S, et al. Eradication of Helicobacter pylori restores elevation of serum gastrin concentrations in patients with end-stage renal disease. Intern Med 1998; 37: 435–9
  • Sipponen P, Graham DY. Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: application of plasma biomarkers. Scand J Gastroenterol 2007; 42: 2–10
  • Wex T, Treiber G, Venerito M, Leodolter A, Peitz U, Kuester D, et al. Helicobacter pylori-induced down-regulation of the secretory leukocyte protease inhibitor (SLPI) in gastric epithelial cell lines and its functional relevance for H. pylori-mediated diseases. Biol Chem 2006; 387: 893–901
  • Rudnick DA, Shikapwashya O, Blomenkamp K, Teckman JH. Indomethacin increases liver damage in a murine model of liver injury from alpha-1-antitrypsin deficiency. Hepatology 2006; 44: 976–82
  • Dallegri F, Ottonello L, Dapino P, Sacchetti C. Effect of nonsteroidal antiinflammatory drugs on the neutrophil-promoted inactivation of alpha-1-proteinase inhibitor. J Rheumatol 1992; 19: 419–23

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.